<?xml version="1.0" encoding="UTF-8"?>
<ref id="B41-vaccines-08-00197">
 <label>41.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Corti</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Voss</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Gamblin</surname>
    <given-names>S.J.</given-names>
   </name>
   <name>
    <surname>Codoni</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Macagno</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Jarrossay</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Vachieri</surname>
    <given-names>S.G.</given-names>
   </name>
   <name>
    <surname>Pinna</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Minola</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Vanzetta</surname>
    <given-names>F.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins</article-title>
  <source>Science</source>
  <year>2011</year>
  <volume>333</volume>
  <fpage>850</fpage>
  <lpage>856</lpage>
  <pub-id pub-id-type="doi">10.1126/science.1205669</pub-id>
  <pub-id pub-id-type="pmid">21798894</pub-id>
 </element-citation>
</ref>
